Launched April 2020
Launched in April 2020, the Health Policy Council is composed of a diverse cross-section of our members who come together to exchange ideas, inform OCC priorities, and advocate to governments.
Mission Statement:
- The Health Policy Council provides timely recommendations to governments related to health care system modernization, innovation, and resilience in Ontario.
- The Council champions the direct connection between a strong health care system and a robust economy.
- The Council recognizes the unique role that the private sector can play in supporting a stronger, more resilient public health care system and achieving positive health outcomes for all Ontarians.
- The Council regularly reviews and updates its priorities to continue to reflect the most pertinent issues impacting Ontario’s health care system.
- The Council creates opportunities for private and public sector organizations to hear directly from one another and expand private sector understanding of public sector health system challenges and opportunities.
Guiding Principles:
- Government investment in Ontario’s health care system is critical for both health and economic resilience.
- Beyond supporting a healthy, productive workforce, a strong, efficient health care system ensures a robust economy, including through job creation, effective delivery of services, improved population health, and research and innovation.
- Equitable access to care and treatment across the province helps to ensure positive health and economic outcomes for Ontario.
- Government investment in preventive health care is an important cost-effective measure for the long-term.
- The private sector plays a critical role in supporting our public health care system by investing in the health and wellbeing of Ontarians both as employers and by providing a variety of services.
Founding members of the Council include:
- 19 to Zero
- Abbott Laboratories
- AbbVie
- Accerta
- Alzheimer Society of Ontario
- Amgen
- AstraZeneca
- BD
- Biogen
- BioMarin
- Boehringer Ingelheim
- Canada Health Infoway
- Dynacare
- Eli Lilly
- Goodlife Fitness
- Green Shield Canada
- GSK
- IMC
- Ingersoll Nurse Practitioner Led Clinic
- Janssen/J&J
- LifeLabs
- Medavie
- Medtronic
- Merck
-
Novartis Pharmaceuticals Canada Inc.
- Novo Nordisk
- Ontario Genomics
- Ontario Medical Association
- Pfizer Canada
- Roche
- Staffy
- Sun Life
- Takeda Canada
- Trudell Medical
- York University
- Zebra Technologies
Click here to learn more about the OCC’s ongoing advocacy work.
Click here to learn more about the OCC’s COVID-19 related advocacy.
For more information on how to join the Council, please contact, Sara Beyer, Senior Policy Analyst